자궁적출 기기 시장 : 질병 유형별, 수술 방법별, 최종 사용자별 - 세계 기회 분석 및 산업 예측(2022-2031년)

According to a new report published by Allied Market Research, titled, "Hysterectomy Device Market," The hysterectomy device market was valued at $328.09 million in 2021, and is estimated to reach $566.5 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031.

The driving factors for hysterectomy device market is rise in prevalence of uterine cancer. Uterine cancer is one of the most common gynecological cancers, and hysterectomy is a common treatment option for this disease. In addition, various government organizations and NGOs are creating awareness among the people about women's health which also fuels the market growth. Moreover, hysterectomy devices have seen a number of technological advancements in recent years, which have improved surgical outcomes, decreased patient discomfort and recovery time also propels the market growth.

However, factors such as availability of alternative treatment for the treatment of gynecological disorders expected to hinder the growth of hysterectomy device market. On the other hand, a surge in demand for minimally or less invasive surgeries is anticipated to offer growth opportunity for the market.

The global hysterectomy device market is segmented into disease type, surgical approach, end user and region. By disease type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic assisted laparoscopic hysterectomy and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major Key players that operate in the global hysterectomy device market are Conkin surgical instruments ltd, Cooper Surgical, B. braun medical ltd, KARL STORZ GmbH & Co. KG, Conmed Corporation, Jhonson & Jhonson, Richard Wolf GmbH, Fortimedix Surgical, Medtronic corporation and Laborie, Inc.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hysterectomy device market analysis from 2021 to 2031 to identify the prevailing hysterectomy device market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the hysterectomy device market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global hysterectomy device market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

• New Product Development/ Product Matrix of Key Players
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Criss-cross segment analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• SWOT Analysis

Key Market Segments

By Surgical approach

• Laparoscopic hysterectomy
• Robotic assisted laparoscopic hysterectomy
• Abdominal hysterectomy
• Vaginal hysterectomy

By Disease type

• Uterine Cancer
• Fibroids
• Chronic pelvic pain
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• B. Braun Melsungen AG
• Conkin surgical instruments ltd
• CONMED Corporation
• Cooper Companies, Inc.
• fortimedix surgical b.v.
• Johnson & Johnson
• KARL STORZ GmbH & Co. KG
• Laborie, Inc
• Medtronic plc
• Richard Wolf GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Moderate threat of substitutes
  • 3.3.2. Moderate intensity of rivalry
  • 3.3.3. High bargaining power of buyers
  • 3.3.4. High bargaining power of suppliers
  • 3.3.5. Moderate threat of new entrants
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Rise in prevalence of uterine cancer
    • 3.4.1.2. Increase in awareness of women's health
    • 3.4.1.3. Technological advancements in hysterectomy devices

• 3.4.2. Restraints
  • 3.4.2.1. Availability of alternative treatments

• 3.4.3. Opportunities
  • 3.4.3.1. Increase in demand for the minimally invasive procedures

• 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Uterine Cancer
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Fibroids
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Chronic pelvic pain
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country
• 4.5. Others
  • 4.5.1. Key market trends, growth factors and opportunities
  • 4.5.2. Market size and forecast, by region
  • 4.5.3. Market share analysis by country

CHAPTER 5: HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Vaginal hysterectomy
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Laparoscopic hysterectomy
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Robotic assisted laparoscopic hysterectomy
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Abdominal hysterectomy
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country

CHAPTER 6: HYSTERECTOMY DEVICE MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Ambulatory Surgical Centers
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Others
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: HYSTERECTOMY DEVICE MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key trends and opportunities
  • 7.2.2. Market size and forecast, by Disease type
  • 7.2.3. Market size and forecast, by Surgical approach
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Key market trends, growth factors and opportunities
    • 7.2.5.1.2. Market size and forecast, by Disease type
    • 7.2.5.1.3. Market size and forecast, by Surgical approach
    • 7.2.5.1.4. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Key market trends, growth factors and opportunities
    • 7.2.5.2.2. Market size and forecast, by Disease type
    • 7.2.5.2.3. Market size and forecast, by Surgical approach
    • 7.2.5.2.4. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Key market trends, growth factors and opportunities
    • 7.2.5.3.2. Market size and forecast, by Disease type
    • 7.2.5.3.3. Market size and forecast, by Surgical approach
    • 7.2.5.3.4. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key trends and opportunities
  • 7.3.2. Market size and forecast, by Disease type
  • 7.3.3. Market size and forecast, by Surgical approach
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Key market trends, growth factors and opportunities
    • 7.3.5.1.2. Market size and forecast, by Disease type
    • 7.3.5.1.3. Market size and forecast, by Surgical approach
    • 7.3.5.1.4. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Key market trends, growth factors and opportunities
    • 7.3.5.2.2. Market size and forecast, by Disease type
    • 7.3.5.2.3. Market size and forecast, by Surgical approach
    • 7.3.5.2.4. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Key market trends, growth factors and opportunities
    • 7.3.5.3.2. Market size and forecast, by Disease type
    • 7.3.5.3.3. Market size and forecast, by Surgical approach
    • 7.3.5.3.4. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Key market trends, growth factors and opportunities
    • 7.3.5.4.2. Market size and forecast, by Disease type
    • 7.3.5.4.3. Market size and forecast, by Surgical approach
    • 7.3.5.4.4. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Key market trends, growth factors and opportunities
    • 7.3.5.5.2. Market size and forecast, by Disease type
    • 7.3.5.5.3. Market size and forecast, by Surgical approach
    • 7.3.5.5.4. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Key market trends, growth factors and opportunities
    • 7.3.5.6.2. Market size and forecast, by Disease type
    • 7.3.5.6.3. Market size and forecast, by Surgical approach
    • 7.3.5.6.4. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key trends and opportunities
  • 7.4.2. Market size and forecast, by Disease type
  • 7.4.3. Market size and forecast, by Surgical approach
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Key market trends, growth factors and opportunities
    • 7.4.5.1.2. Market size and forecast, by Disease type
    • 7.4.5.1.3. Market size and forecast, by Surgical approach
    • 7.4.5.1.4. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Key market trends, growth factors and opportunities
    • 7.4.5.2.2. Market size and forecast, by Disease type
    • 7.4.5.2.3. Market size and forecast, by Surgical approach
    • 7.4.5.2.4. Market size and forecast, by End User
    • 7.4.5.3. India
    • 7.4.5.3.1. Key market trends, growth factors and opportunities
    • 7.4.5.3.2. Market size and forecast, by Disease type
    • 7.4.5.3.3. Market size and forecast, by Surgical approach
    • 7.4.5.3.4. Market size and forecast, by End User
    • 7.4.5.4. Australia
    • 7.4.5.4.1. Key market trends, growth factors and opportunities
    • 7.4.5.4.2. Market size and forecast, by Disease type
    • 7.4.5.4.3. Market size and forecast, by Surgical approach
    • 7.4.5.4.4. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Key market trends, growth factors and opportunities
    • 7.4.5.5.2. Market size and forecast, by Disease type
    • 7.4.5.5.3. Market size and forecast, by Surgical approach
    • 7.4.5.5.4. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Key market trends, growth factors and opportunities
    • 7.4.5.6.2. Market size and forecast, by Disease type
    • 7.4.5.6.3. Market size and forecast, by Surgical approach
    • 7.4.5.6.4. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key trends and opportunities
  • 7.5.2. Market size and forecast, by Disease type
  • 7.5.3. Market size and forecast, by Surgical approach
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Key market trends, growth factors and opportunities
    • 7.5.5.1.2. Market size and forecast, by Disease type
    • 7.5.5.1.3. Market size and forecast, by Surgical approach
    • 7.5.5.1.4. Market size and forecast, by End User
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Key market trends, growth factors and opportunities
    • 7.5.5.2.2. Market size and forecast, by Disease type
    • 7.5.5.2.3. Market size and forecast, by Surgical approach
    • 7.5.5.2.4. Market size and forecast, by End User
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Key market trends, growth factors and opportunities
    • 7.5.5.3.2. Market size and forecast, by Disease type
    • 7.5.5.3.3. Market size and forecast, by Surgical approach
    • 7.5.5.3.4. Market size and forecast, by End User
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Key market trends, growth factors and opportunities
    • 7.5.5.4.2. Market size and forecast, by Disease type
    • 7.5.5.4.3. Market size and forecast, by Surgical approach
    • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

• 9.1. Conkin surgical instruments ltd
  • 9.1.1. Company overview
  • 9.1.2. Key Executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
• 9.2. KARL STORZ GmbH & Co. KG
  • 9.2.1. Company overview
  • 9.2.2. Key Executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
• 9.3. CONMED Corporation
  • 9.3.1. Company overview
  • 9.3.2. Key Executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
• 9.4. Richard Wolf GmbH
  • 9.4.1. Company overview
  • 9.4.2. Key Executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
• 9.5. fortimedix surgical b.v.
  • 9.5.1. Company overview
  • 9.5.2. Key Executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
• 9.6. Johnson & Johnson
  • 9.6.1. Company overview
  • 9.6.2. Key Executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
  • 9.6.6. Business performance
• 9.7. Laborie, Inc
  • 9.7.1. Company overview
  • 9.7.2. Key Executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
• 9.8. Cooper Companies, Inc.
  • 9.8.1. Company overview
  • 9.8.2. Key Executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Business performance
  • 9.8.7. Key strategic moves and developments
• 9.9. B. Braun Melsungen AG
  • 9.9.1. Company overview
  • 9.9.2. Key Executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
• 9.10. Medtronic plc
  • 9.10.1. Company overview
  • 9.10.2. Key Executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance